[18F] FMH3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F] FMH3, covering 2013-11-11 to 2013-11-11. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC [EARLY_Phase 1]